Explore every episode of the podcast Innovating Tomorrow's Medicine

Sneak Peek from episode VII of my video podcast: Innovating Tomorrow’s Medicine ft. Pilgrim Jackson⁠, CEO of Yatiri Bio Inc. decoding proteins to predict treatment response in Acute Myeloid Leukemia (AML) and Ovarian Cancer.

In this exclusive preview, Pilgrim shares a glimpse into: What proteomic signatures they have found that differentiate responders from non-responders in AML and ovarian cancer. De-risking clinical trial design in oncology, especially with regard to patient heterogeneity.

➡️ Full episode launches on 18 December

🔔 Subscribe and hit the bell so you don’t miss it!

🎙️ About the Show:

Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.

📌 Stay tuned for the full interview where we explore and share unique insights:

– What inspired the founding of Yatiri Bio Inc. and decoding proteins to predict treatment response

– Why they chose to focus on AML and ovarian cancer as lead indications

– Proteomics in Oncology

– Targets, Modalities & Resistance

– regulatory strategy, when it comes to stratified trials or biomarker-linked therapies

– Personal reflections and future outlook

⁠⁠#SneakPeek⁠⁠⁠⁠

#PilgrimJackson

#YatiriBio⁠⁠⁠

#FutureOfMedicine⁠⁠

Full Episode: Innovating Tomorrow’s Medicine ft. Rick Stweart.In this episode, Rick shares a glimpse into Achieve Life Sciences and Cytisinicline which is redefining the future of nicotine dependence.➡️ Full episode launches on 4 December 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.📌 Stay tuned for the full interview where we explore and share unique insights:– FDA acceptance for its cytisinicline New Drug Application (NDA)– Commercial Readiness– Financial strategy and capital efficiency– Market impact and public health–Engagement and investor relations – Personal reflections and futureoutlook#SneakPeek#Rick Stewart#FutureOfMedicine

Sneak Peek: Innovating Tomorrow’s Medicine ft. Rick Stweart.In this exclusive preview, Rick shares a glimpse into Achieve Life Sciences and Cytisinicline which is redefining the future of nicotine dependence.➡️ Full episode launches on 4 December 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.📌 Stay tuned for the full interview where we explore and share unique insights:– FDA acceptance for its cytisinicline New Drug Application (NDA)– Commercial Readiness– Financial strategy and capital efficiency– Market impact and public health–Engagement and investor relations – Personal reflections and futureoutlook#SneakPeek#Rick Stewart#FutureOfMedicine

Full Episode: Innovating Tomorrow’s Medicine ft. Sheila Gujrathi, MD, biotech entrepreneur and executive, healthcare investor, and drug developer with over 25 years of experience in the industry. She’s founded, built, and run numerous biotech companies, and led the development and approval of life-changing pharmaceutical drugs, including Orencia® and Nulojix®.In this episode, Sheila shares a glimpse into:The Spiritual Foundation of Biotech Leadership and "The Mirror Effect" a new book and leadership framework that just launched on 4 November 2025 and is already officially an Amazon Bestseller.➡️ Full episode launches on 20 November 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.📌 Stay tuned for the full interview where we explore and share unique insights:– The Spiritual Foundation of Biotech Leadership – Deal-Making & Corporate Strategy– The Science & the Pipeline– Diversity, Inclusion & the Biotech CEO Sisterhood – Personal reflections and future outlook#SneakPeek#SheilaGujrathi#FutureOfMedicine

Sneak Peek: Innovating Tomorrow’s Medicine ft. Sheila Gujrathi, MD, biotech entrepreneur and executive, healthcare investor, and drug developer with over 25 years of experience in the industry. She’s founded, built, and run numerous biotech companies, and led the development and approval of life-changing pharmaceutical drugs, including Orencia® and Nulojix®.In this exclusive preview, Sheila shares a glimpse into:The Spiritual Foundation of Biotech Leadership and "The Mirror Effect" a new book and leadership framework that just launched on 4 November 2025 and is already officially an Amazon Bestseller.➡️ Full episode launches on 20 November 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.📌 Stay tuned for the full interview where we explore and share unique insights:– The Spiritual Foundation of Biotech Leadership – Deal-Making & Corporate Strategy– The Science & the Pipeline– Diversity, Inclusion & the Biotech CEO Sisterhood – Personal reflections and future outlook#SneakPeek#SheilaGujrathi#FutureOfMedicine

Full Episode: Innovating Tomorrow’s Medicine ft. Rick Fultz, CEO of Acurion, Inc. whose mission is to bring the power of precision medicine to more cancer patients, faster.In this exclusive preview, Rick shares a glimpse into how Acurion is transforming the field of precision oncology using next-generation science and strategic biotech leadership.➡️ Full episode launches on 30 October 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.📌 Stay tuned for the full interview where we explore and share unique insights:– The vision behind Acurion – New approaches using AI in precision medicine– Fund raising– Leadership and culture– Personal reflections and future outlook#SneakPeek#RickFultz#Acurion#Biocom#FutureOfMedicine

Sneak Peek: Innovating Tomorrow’s Medicine ft. Rick Fultz, CEO of Acurion, Inc. whose mission is to bring the power of precision medicine to more cancer patients, faster.In this exclusive preview, Rick shares a glimpse into how Acurion is transforming the field of precision oncology using next-generation science and strategic biotech leadership.➡️ Full episode launches on 30 October 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.📌 Stay tuned for the full interview where we explore and share unique insights:– The vision behind Acurion – New approaches using AI in precision medicine– Fund raising– Leadership and culture– Personal reflections and future outlook#SneakPeek#RickFultz#Acurion#Biocom#FutureOfMedicine

Full Episode – Innovating Tomorrow’s Medicine ft. Dr. Courtney Young, CEO of MyoGene Bio.

In this exclusive preview, Dr. Courtney Young shares a glimpse into how MyoGene Bio is transforming the field of Duchenne Muscular Dystrophy using the gene editing technology CRISPR.

➡️ Full episode launches on 11 September

🔔 Subscribe and hit the bell so you don’t miss it!

🎙️ About the Show: Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.

📌 Stay tuned for the full interview where we explore and share unique insights:

– The vision behind MyoGene Bio

– CRISPR and Duchenne Muscular Dystrophy

– Fund raising

– Leadership and culture

– Personal reflections and future outlook

#SneakPeek #Courtney Young #MyoGene Bio #Biotech #Cancer #FutureOfMedicine

Sneak Peek – Innovating Tomorrow’s Medicine ft. Dr. Courtney Young, CEO of MyoGene Bio.

In this exclusive preview, Dr. Courtney Young shares a glimpse into how MyoGene Bio is transforming the field of Duchenne Muscular Dystrophy using the gene editing technology CRISPR.

➡️ Full episode launches on 11 September

🔔 Subscribe and hit the bell so you don’t miss it!

🎙️ About the Show: Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.

📌 Stay tuned for the full interview where we explore and share unique insights:

– The vision behind MyoGene Bio

– CRISPR and Duchenne Muscular Dystrophy

– Fund raising

– Leadership and culture

– Personal reflections and future outlook

#SneakPeek #Courtney Young #MyoGene Bio #Biotech #Cancer #FutureOfMedicine

Full Episode – Innovating Tomorrow’s Medicine ft. Dr. Stanley Lewis, CEO of A28 Therapeutics.

Dr. Stanley Lewis shares a glimpse into how A28 Therapeutics is transforming the field of cancer using lytic peptides as a novel payload.

➡️ Full episode launches on 28 August

🔔 Subscribe and hit the bell so you don’t miss it!

🎙️ About the Show: Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.

📌 Stay tuned for the full interview where we explore and share unique insights:

– The vision behind A28 Therapeutics

– Next-generation payload for cancer therapy

– Role of AI and machine learning in R&D

– Fund raising

– Leadership and culture

– Personal reflections and future outlook

#SneakPeek #StanleyLewis #A28Therapeutics #Biotech #Cancer #FutureOfMedicine

Sneak Peek – Innovating Tomorrow’s Medicine ft. Dr. Stanley Lewis, CEO of A28 Therapeutics.

In this exclusive preview, Dr. Stanley Lewis shares a glimpse into how A28 Therapeutics is transforming the field of cancer using lytic peptides as a novel payload.

➡️ Full episode launches on 28 August

🔔 Subscribe and hit the bell so you don’t miss it!

🎙️ About the Show: Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.

📌 Stay tuned for the full interview where we explore and share unique insights:

– The vision behind A28 Therapeutics

– Next-generation payload for cancer therapy

– Role of AI and machine learning in R&D

– Fund raising

– Leadership and culture

– Personal reflections and future outlook

#SneakPeek #StanleyLewis #A28Therapeutics #Biotech #Cancer #FutureOfMedicine

Full Episode – Innovating Tomorrow’s Medicine ft. Dr. James Mackay, CEO of Crystalys TherapeuticsDr. James Mackay shares a glimpse into how Crystalys Therapeutics is transforming the field of rheumatology using next-generation science and strategic biotech leadership.➡️ Full episode launches on 14 August 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.📌 Stay tuned for the full interview where we explore and share unique insights:– The vision behind Crystalys Therapeutics – New approaches in rheumatology– Approach to risk management– Fund raising– Leadership and culture– Personal reflections and future outlook#SneakPeek #JamesMackay #CrystalysTherapeutics #Biotech #Rheumatology #FutureOfMedicine

Sneak Peek – Innovating Tomorrow’s Medicine ft. Dr. James Mackay, CEO of Crystalys Therapeutics.

In this exclusive preview, Dr. James Mackay shares a glimpse into how Crystalys Therapeutics is transforming the field of rheumatology using next-generation science and strategic biotech leadership.

➡️ Full episode launches on 14 August

🔔 Subscribe and hit the bell so you don’t miss it!

🎙️ About the Show: Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.

📌 Stay tuned for the full interview where we explore and share unique insights:

– The vision behind Crystalys Therapeutics

– New approaches in rheumatology

– Approach to risk management

– Fund raising

– Leadership and culture

– Personal reflections and future outlook

#SneakPeek #JamesMackay #CrystalysTherapeutics #Biotech #Rheumatology #FutureOfMedicine

Official trailer for video podcast Innovating Tomorrow’s Medicine. In this series, Dr. Jeff Trickett explores the challenges faced by those biotech industry leaders shaping the future of medical treatments. Discover the strategies they’re using and the insights behind their success. Join him as we uncover these breakthroughs and explore how we can innovate medicine together. From AI in diagnostics to gene editing, digital therapeutics, and beyond Innovating Tomorrow’s Medicine brings together conversations with leading minds who are redefining what's possible in medicine.

🧬 Bold ideas.

🧠 Visionary innovators.

💡 The science of tomorrow in focus today.

🎧 Watch the trailer and tune into the episodes now.